| Literature DB >> 34937231 |
Pradeep Susvar1, Niharika Singh1, Pramod Bhende1, Chetan Rao1.
Abstract
PURPOSE: : To report the anatomic and visual outcomes following macular buckling in patients affected by pathological myopia-associated foveoschisis (FS) and macular detachment with or without macular hole (MH).Entities:
Keywords: Macular buckle; macular detachment; macular hole; myopic foveoschisis; myopic tractional maculopathy; pathological myopia; posterior staphyloma; vitrectomy
Mesh:
Year: 2022 PMID: 34937231 PMCID: PMC8917523 DOI: 10.4103/ijo.IJO_3720_20
Source DB: PubMed Journal: Indian J Ophthalmol ISSN: 0301-4738 Impact factor: 1.848
Figure 1Three-dimensional reconstruction of a right eye and a T-shaped macular buckle
Figure 2Surgical procedure. (a) Threading of Morin band into Devin’s wedge. (b) Passing the band under the lateral rectus. (c) Passing one end of band under inferior rectus and inferior oblique muscle. (d) Tagging the superior rectus and oblique muscle together and passing the other of band underneath it. (e) The flatter end of wedge is adjusted under lateral rectus with wedge toward the macula. (f) Insertion of 25G chandelier light. (g) Adjusting the macular indention under direct visualization. (h) Finalizing the suture of plate end under lateral rectus on either side. (i) The nasal end of bands are marked on sclera after adjusting the indentation and sutured and the free edges trimmed. (j) Conjunctiva is liberally mobilized. (k) Suturing of conjunctiva and tendons in two layers carefully. Combined cases with vitrectomy the Morin–Devin wedge is passed in similar manner followed by (l) 25G sclerotomies made 3.5 mm from limbus. (m) Vitrectomy is done with posterior vitreous detachment and followed by fluid gas exchange. (n) ILM peeling using forceps. Followed by adjustment of buckle under air and (o) finalizing the sutures of MB. (p) Silicone oil infusion and buckle indent appreciated at posterior pole
Demographic, clinical characteristics, and details of surgical procedure
| No. | Age | Eye | VA pre-op | Preoperative axial length | Surgery | VA final at last visit | Axial length at last visit | Follow-up (months) | Complication |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 52 | OS | 1.30 | Oil filled | MB | 1.3 | Oil filled | 54 | Nil |
| 2 | 64 | OS | 1.50 | 26 | MB | 1.3 | 25 | 2 | Subretinal hemmorhage |
| 3 | 59 | OD | 1.70 | 26 | MB+V+SOI | 1.5 | 24 | 24 | Nil |
| 4 | 50 | OD | 2.30 | 26 | MB+V+SOI | 1.3 | 27 | 48 | Nil |
| 5 | 59 | OS | 1.00 | 26.1 | MB | 1 | 28.2 | 14 | Nil |
| 6 | 67 | OD | 1.50 | 30 | MB+V+SOI | 1.5 | Oil filled | 6 | Nil |
| 7 | 35 | OD | 1.00 | 26.2 | MB | 0.8 | 25.1 | 2 | Nil |
| 8 | 48 | OS | 0.80 | 28.8 | MB | 0.9 | 24.2 | 2 | Choroidal detachment |
| 9 | 47 | OD | 1.00 | 27.7 | MB | 0.6 | 24.5 | 6 | Nil |
| 10 | 43 | OD | 1.30 | 29.8 | MB | 1 | 27 | 2 | Subretinal hemmorhage |
| 11 | 48 | OS | 1.50 | 26 | MB | 1.7 | 25.7 | 6 | Subretinal hemmorhage |
| 12 | 39 | OS | 1.70 | 28.9 | MB+V+SOI | 1 | Oil filled | 36 | Nil |
| 13 | 37 | OD | 1.30 | 26.5 | MB | 1.3 | 24 | 2 | Nil |
| 14 | 68 | OD | 0.80 | 29.9 | MB+V+SOI | 1.3 | 29 | 36 | Nil |
| 15 | 65 | OS | 0.60 | 27.9 | MB | 0.5 | 24.9 | 2 | Nil |
| 16 | 61 | OS | 1.40 | 27.4 | MB | 1.4 | 24 | 2 | Nil |
| 17 | 57 | OD | 1.30 | 28 | MB | 1.3 | 25 | 3 | Nil |
| 18 | 50 | OD | 0.50 | 30.70 | MB | 0.50 | 28 | 2 | Nil |
| 19 | 54 | OS | 0.20 | 27.7 | MB | 0.2 | 25.5 | 2 | Nil |
| 20 | 50 | OD | 0.50 | 33.5 | MB | 2 | 26 | 8 | Choroidal detachment |
| 21 | 57 | OD | 1.00 | 30 | MB | 0.8 | 29.2 | 30 | Angle closure glaucoma |
| 22 | 66 | OD | 2.30 | Oil filled | MB | 2.3 | Oil filled | 2 | Nil |
| 23 | 74 | OS | 1.30 | 27.3 | MB | 0.7 | 26 | 3 | Nil |
| 24 | 50 | OD | 0.50 | 33.8 | MB | 0.5 | 29.3 | 2 | Nil |
| 25 | 57 | OS | 0.70 | 31.4 | MB | 0.7 | 27.8 | 24 | Angle closure glaucoma |
Figure 3Preoperative (A1, A2, A3) and postoperative OCT (B1, B2, B3). Case 1: Patient having MHRD, after MB. There is closure of hole with good indentation at macular region. Case 2: Patient with isolated macular detachment after surgery. There was good indentation at macula but residual fluid surrounding it, which subsequently absorbed. Case 3: Patient having retinoschisis with foveal retinal detachment after surgery. There was resolution of schisis with retinal reattachment
Comparison of preoperative and postoperative best-corrected visual acuity outcomes
| VA. Status | VA. Preop | VA. Postop | Difference |
| |
|---|---|---|---|---|---|
| Improved | Mean | 1.340 | 0.950 | 0.390 | 0.005 |
|
| 10 | 10 | 10 | ||
| Std. deviation | 0.484 | 0.331 | 0.288 | ||
| Stable | Mean | 1.091 | 1.091 | 0.000 | 0.991 |
|
| 11 | 11 | 11 | ||
| Std. deviation | 0.592 | 0.592 | 0.000 | ||
| Worsened | Mean | 0.900 | 1.475 | −0.575 | 0.068 |
|
| 4 | 4 | 4 | ||
| Std. deviation | 0.424 | 0.479 | 0.640 | ||
| Total | Mean | 1.160 | 1.096 | 0.064 | 0.165 |
|
| 25 | 25 | 25 | ||
| Std. deviation | 0.532 | 0.499 | 0.443 | ||
Potential factors affecting anatomical outcome
| Factors | Anatomical success | ||
|---|---|---|---|
|
| |||
| Favorable ( | Unfavorable ( | ||
| Age | 52.36±10.04 | 56.7±10.6 | 0.341 |
| Duration of symptoms (weeks) | 20.14±40.1 | 16.86±18.53 | 0.536 |
| VR surgery-absent | 13 (92.86%) | 9 (81.82%) | 0.42 |
| VR surgery-present | 1 (7.14%) | 2 (18.18%) | |
| Initial BCVA | 1.1±0.59 | 1.24±0.47 | 0.609 |
| Final BCVA | 1.07±0.51 | 1.13±0.51 | 0.979 |
| Axial length | 28.6±2.32 | 28.24±2.63 | 0.688 |
| Staphyloma type - 1 | 6 (42.86%) | 6 (54.55%) | 0.393 |
| Staphyloma type -2 | 6 (42.86%) | 2 (18.18%) | |
| Staphyloma-9 | 2 (14.29%) | 3 (27.27%) | |
| Staphyloma grade 1 | 7 (50%) | 4 (36.36%) | 0.495 |
| Staphyloma grade >1 | 7 (50%) | 7 (63.64%) | |
| Only PMB | 9 (64.29%) | 11 (100%) | 0.027 |
| PMB+Vit | 5 (35.71%) | 0 (0%) | |
| SRF. Preop | 1209.21±1487.86 | 992.18±563.02 | 0.893 |
| Change in SRF | 1207±1488.72 | 399.18±717.18 | 0.134 |
| Preoperative height of retinoschitic cavity | 410.86±338.88 | 296.09±159.92 | 0.647 |
| Change in retinoschitic height | 357.21±356.97 | 134.36±164.09 | 0.058 |
| FTMH-No | 14 (61.9%) | 2 (50%) | 0.656 |
| FTMH-Yes | 7 (38.1%) | 2 (50%) | |
| LMH-No | 13 (61.9%) | 2 (50%) | 0.656 |
| LMH-Yes | 8 (38.1%) | 2 (50%) | |
Potential factors affecting functional outcome
| Factors | Functional success | ||
|---|---|---|---|
|
| |||
| Favorable ( | Unfavorable ( | ||
| Age | 54.3±10.63 | 53.5±9.71 | 0.737 |
| Duration of symptoms (weeks) | 13.79±15.02 | 44.5±74.66 | 0.915 |
| Previous VR surgery | |||
| Absent | 18 (85.71%) | 4 (100%) | 0.42 |
| Present | 3 (14.29%) | 0 (0%) | |
| Initial BCVA | 1.21±0.54 | 0.9±0.42 | 0.331 |
| Final BCVA | 1.02±0.48 | 1.48±0.48 | 0.113 |
| Axial length | 28.22±2.25 | 29.6±3.09 | 0.456 |
| Staphyloma type 1 | 10 (47.62%) | 2 (50%) | 0.934 |
| Staphyloma type 2 | 7 (33.33%) | 1 (25%) | |
| Staphyloma 9 | 4 (19.05%) | 1 (25%) | |
| Staphyloma grade-1 | 10 (47.62%) | 1 (25%) | 0.404 |
| Staphyloma grade >1 | 11 (52.38%) | 3 (75%) | |
| Only PMB | 17 (80.95%) | 3 (75%) | 0.785 |
| PMB+Vit | 4 (19.05%) | 1 (25%) | |
| Preoperative height of SRF | 1189.67±1224.8 | 715±702.11 | 0.452 |
| Change in SRF | 877.57±1349.21 | 715±702.11 | 0.858 |
| Preoperative height of retinoschitic cavity | 364.29±300.32 | 339.75±89.38 | 0.971 |
| Change in retinoschitic height | 261.48±332.57 | 247±79.39 | 0.642 |
| FTMH-No | 14 (61.9%) | 2 (50%) | 0.656 |
| FTMH-Yes | 7 (38.1%) | 2 (50%) | |
| LMH-No | 13 (61.9%) | 2 (50%) | 0.656 |
| LMH-Yes | 8 (38.1%) | 2 (50%) | |
Figure 4(A) Preoperative fundus photograph with macular retinal detachment (MRD). (B) 24 months postoperative fundus photograph with retina reattachment. (C) Preoperative (C1) and 24 months postoperative (C2) optical coherence tomography examination. (D) Preoperative (D1) and 24 months postoperative (D2) ultrasonography image showing buckle indent and shortening of axial length